Ibrutinib 140 mg - Ibrucent

Ibrucent 140 (Ibrutinib) is a kinase inhibitor used to treat:

1. Mantle cell lymphoma (MCL) who have received at least one prior therapy.
2.

Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)..
4. Waldenström’s macroglobulinemia (WM)